Navigation Links
ISS and Glass Lewis Recommend Cholestech Stockholders Vote 'FOR' Merger
Date:9/10/2007

urnment proposal.

Cholestech urges all stockholders to vote "FOR" the merger transaction, consistent with the recommendations of ISS, Glass- Lewis and Cholestech's board of directors.

Since approval of the merger requires the affirmative vote of at least a majority of the outstanding shares, each Cholestech stockholder's vote is extremely important, regardless of the number of shares owned. A failure to vote will have the same effect as a vote against the transaction.

Cholestech stockholders should vote by telephone or by Internet by following the easy instructions on the proxy card, or by signing, dating and returning the proxy card promptly to ensure their shares are voted.

Cholestech's Special Meeting of Stockholders will be held on September 12, 2007 at 10:00 a.m., local time, at Cholestech's executive offices at 3347 Investment Boulevard, Hayward, California 94545.

About Cholestech

Cholestech is committed to enabling people to lead longer, healthier and more active lives. Cholestech provides easy to use, accessible diagnostic tools and information to health care practitioners in over 35 countries around the world. Cholestech offers efficient and economic diagnostic testing for cholesterol and related lipids, blood glucose and glycemic control, and liver enzymes at the point of care. Health care providers can use the CLIA-waived Cholestech LDX(R) and GDX(TM)* Systems and the hs-CRP test, which is cleared by the FDA for use in moderate complexity labs, to initiate and monitor the progress of patient therapy. By providing effective disease management solutions, Cholestech's goal is to be a leading provider of diagnostic tools and information for immediate risk assessment and therapeutic monitoring of heart disease, inflammatory disorders and diabetes. *The GDX system is 510(k) cleared for prescription home use and, accordingly, is CLIA waived.

Cholestech LDX is a registered trademark and Cholestech GDX is a trademark of Ch
'/>"/>

SOURCE Cholestech Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Short Glasses Make You Drink More
2. Over indulgence more so when intake is in short glasses
3. A Glass, Half Filled With Water Is Half Full Or Half Empty?
4. Sunglasses Can Really Pull a Fast One on the Biological Clock, and Set a Lag in the Build Up Of Jet Lag
5. Watch Out! Eye Glass Related Injuries On The Rise
6. Efforts To Replace Reading Glasses Are In View
7. Metallic and Glass Objects Retreived from Womens Stomach
8. A sty in Actress Konkona Sharma Disrupts the Shooting of Bi- Lingual movie Sunglass
9. A Glass of Orange Juice To Keep Recurrence Of Kidney Stones At Bay
10. Cataract Surgery to Eliminate Reading Glasses?
11. Quest for an hour glass figure results in rise of eating disorders by the hour
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2015)... April 26, 2015 With the FCPX LUT ... X editors can quickly and easily add desaturated color ... contains a mathematical formula for modifying an image. The LUT ... the table. This pack comes with 60 black and white ... and contemporary black and white films. With the FCPX ...
(Date:4/26/2015)... April 26, 2015 In an article ... University evaluated the head-neck biomechanics occurring during the use of ... were able to determine that use of a tablet increases ... to 5 times - more than when the neck is ... such a study, but pointing out the potential hazards of ...
(Date:4/25/2015)... Diversified Communications has announced the launch ... Integrative Healthcare Symposium Canada, as it’s titled, will ... Sheraton Parkway Toronto North in Ontario. , The ... most anticipated events of the year and will ... event aims to gather multi-disciplined practitioners from all ...
(Date:4/25/2015)... 2015 The federal multidistrict litigation ... filed against C.R. Bard, Inc. continues to move ... of West Virginia. According to a Pretrial Order ... that day, after certain defendants submitted amended responses ... Order directed that any Preliminary Motions referenced during ...
(Date:4/25/2015)... 25, 2015 Gardant Management Solutions ... management and operations, and sales and marketing at ... scheduled to be held from April 29 through ... is the largest eldercare association in Illinois. The ... for older adults, including senior housing, assisted living ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios, a FCPX Effects Developer, Announced the Release of FCPX LUT B&W 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4Health News:Integrative Healthcare Event launching in Canada 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 4Health News:Gardant Management Solutions Staff Shares Operational Expertise 2
... participate in school-sponsored and club-level gymnastics competitions annually in ... in terms of potential for injury, while having one ... , A study, conducted by researchers in the Center ... Institute at Nationwide Childrens Hospital and published in the ...
... 4, 2008 Dialysis,Corporation of America (Nasdaq: DCAI ... its eleventh facility in that state., President & ... our growth in Pennsylvania, one of our core markets ... superior quality,care for the patients we are responsible for ...
... April 4, 2008 Companies align,commercial and portfolio ... an annual sales volume of $10 to 20 ... the early-stage commercialization team along,with approximately eight portfolio ... is approximately four to three, commercial to,portfolio management ...
... INDIANAPOLIS, April 4, 2008 Eli Lilly and ... European Commission has approved a new,indication for FORSTEO(R) ... associated with sustained, systemic,glucocorticoid therapy in women and ... the initial positive opinion issued in February by,the ...
... 2008 To promote,the U.S. Department of ... a,Healthy Future" initiative, Acting U.S. Surgeon General ... with several community leaders at A.I.,DuPont Hospital ... reducing,childhood obesity in Delaware., (Photo: httphttp://www.newscom.com/cgi-bin/prnh/20080403/18521), ...
... 2008 Targeted mass,media campaigns alone can ... young adults to adopt safer,sex practices, according ... of,Communication at the University of Kentucky with ... Past public health campaigns, particularly those ...
Cached Medicine News:Health News:Dialysis Corporation of America Announces the Development of a New Facility in Pennsylvania 2Health News:Early-stage Commercialization Success: Pharma Companies Adjust Resources in Light of Industry Changes 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 2Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 3Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 4Health News:FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis 5Health News:Delaware's Campaign to Make Kids Healthy Gets Boost from US Top Doc 2Health News:Delaware's Campaign to Make Kids Healthy Gets Boost from US Top Doc 3Health News:Study Finds Mass Media Campaigns Alone Can Effectively Reduce High-Risk Sexual Behavior Among Impulsive, Sensation-Seeking Young Adults 2Health News:Study Finds Mass Media Campaigns Alone Can Effectively Reduce High-Risk Sexual Behavior Among Impulsive, Sensation-Seeking Young Adults 3
(Date:4/24/2015)... , April 24, 2015  Lannett Company, Inc. ... amended and increased its five-year revolving credit facility to ... an accordion feature that will allow the company to ... additional $30.0 million, subject to securing additional commitments from ... of the credit facility remains December 18, 2018.   ...
(Date:4/23/2015)... CHICAGO, Ill. , April 24, 2015  AbbVie ... Food and Drug Administration (FDA) has accepted its New ... company,s, all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, ... for the treatment of adults with chronic genotype 4 ... regimen is the first all-oral, interferon-free therapy being evaluated ...
(Date:4/23/2015)... Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that ... on Thursday, May 7, 2015, after the close of ... audio webcast immediately following the announcement at 4:30 p.m. ... results and provide a business and financial update. ... via the Investors & Media section of the Jazz ...
Breaking Medicine Technology:Lannett Expands Revolving Credit Facility To $120 Million 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7Jazz Pharmaceuticals to Report 2015 First Quarter Financial Results on May 7, 2015 2
... NOVATO, Calif., Sept. 30 BioMarin Pharmaceutical Inc. (Nasdaq: ... and Trademark Office has allowed claims covering the approved ... the discovery that food increases the bioavailability of Kuvan. ... in 2024, will officially issue later this year. , ...
... Delaware-based company specializing in pharmaceutical risk management and optimal ... chief marketing executive in a move to expand the ... served as interim vice president of business development, sales ... consultant to Acurian and NanoScan Imaging. She is ...
Cached Medicine Technology:United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food 2United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food 3
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
... international engineering and design specifications, Smith ... System* provides seamless integration with existing ... open reduction internal fixational procedures (AO ... well beyond the standard, providing a ...
... has been developed for the transvenous closure ... venous sheaths the device offers a safe ... of ASD's with a super low profile.,A ... twelve arm device for optimal positioning and ...
Stainless steel threaded Steinman Pins available in point types A,D, E, and F....
Medicine Products: